Search:
Latest News
|
22 May 2012
-1 Likes
The Food and Drug Administration Safety and Innovation Act (FDASIA), the Senate’s iteration of a package of user fee legislation and other regulatory reforms, advanced in the Senate on 21 May, moving
[Read More...]
Latest News
|
18 May 2012
0 Likes
The long-running and surprisingly quick saga of the Food and Drug Administration Safety and Innovation Act (FDASIA) may have just encountered its first, albeit minor, setback.Senate Majority Leader
[Read More...]
Latest News
|
17 May 2012
0 Likes
The Obama Administration has indicated it “strongly supports passage” of user fee legislation currently in the US Senate, saying it will “help speed safe and effective drugs, medical devices and
[Read More...]
Latest News
|
17 May 2012
0 Likes
The Senate is scheduled to take up the Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on Thursday, 17 May, and numerous sources report new provisions have entered into the
[Read More...]
Latest News
|
15 May 2012
0 Likes
A Senate hearing being held by Senator Bernie Sanders (I-VT) seeks to advance legislation that would create a prize fund for companies to create new medicines and vaccines, partially replacing the
[Read More...]
Latest News
|
14 May 2012
0 Likes
The US Senate’s Food and Drug Administration Safety and Innovation Act (FDASIA) is a expected to save taxpayers $358 million over the coming decade, with $71 million in savings in the next five years
[Read More...]
Latest News
|
11 May 2012
0 Likes
In early 2011, several bills aiming to curb drug shortages were introduced in the US House of Representatives and the US Senate. Despite the bills’ bipartisan nature and widespread support, they’ve
[Read More...]
Latest News
|
10 May 2012
0 Likes
The House Energy and Commerce Committee advanced the Food and Drug Administration (FDA) Reform Act of 2012, a package of proposals to both fund and reform the agency, by a unanimous vote involving 46
[Read More...]
Latest News
|
10 May 2012
0 Likes
Explosive allegations have emerged from two prominent Senators regarding marketing tactics used by a number of pharmaceutical companies, including Purdue Pharma, Endo Pharmaceuticals and Johnson &
[Read More...]
Latest News
|
10 May 2012
0 Likes
The US House of Representatives’ Energy and Commerce Committee is set to hold a vote on Thursday, 10 May on a collection of user fee legislation being dubbed the Food and Drug Administration (FDA)
[Read More...]